ServicenavigationHauptnavigationTrailKarteikarten


Forschungsstelle
COST
Projektnummer
C16.0038
Projekttitel
Medicine Shortages - Reframing and negotiations of agreement between key players and stakeholders
Projekttitel Englisch
Medicine Shortages - Reframing and negotiations of agreement between key players and stakeholders

Texte zu diesem Projekt

 DeutschFranzösischItalienischEnglisch
Schlüsselwörter
-
-
-
Anzeigen
Forschungsprogramme
-
-
-
Anzeigen
Kurzbeschreibung
-
-
-
Anzeigen
Partner und Internationale Organisationen
-
-
-
Anzeigen
Abstract
-
-
-
Anzeigen
Datenbankreferenzen
-
-
-
Anzeigen

Erfasste Texte


KategorieText
Schlüsselwörter
(Englisch)
Medicines; shortages; healthcare; patients; supply chain; multidisciplinary collaboration; shared responsibility;action research; systems research
Forschungsprogramme
(Englisch)
COST-Action CA15105 - European Medicines Shortages Research Network – addressing supply problems to patients
Kurzbeschreibung
(Englisch)
ln a 2013 survey, 99% of over 300 hospital pharmacist respondents from 27 European countries including Switzerland recorded increasing problems with medicine shortages in their hospital. Furthermore, 63% reported to experience shortage problems on a weekly, sometimes even on a daily basis. Besides patient welfare and safety considerations, substituting an alternative medicinal product is cost-intensive compared to using the initial standard product. A simple intermediate substitution of a drug on the formulary can, in an example from Germany, cost 1800 €, a definite substitution between 3800 € and 4690 €. This project will make a significant contribution to strategic thinking about how to respond to product shortage problems by systematically analyzing the situation from key player perspectives. This includes knowledgeelaboration, integration, and sharing about the extent and the causal factors of shortages as well as round table negotiations with the stakeholders which will make out shared responsibilities. It is the declared aim of the project to bring together all the primary stakeholders in the medicines supply chain process to find an agreement on the paths towards resolution. The final objective is to stimulate constructive agreement between all participating stakeholders and to reveal any restrictive legal and economic frameworks, erroneous incentives in the supply chain, conflicts of interest, and problematic cost-benefit ratios that induce or exacerbate shortages.
Partner und Internationale Organisationen
(Englisch)
AT; BE; BA; HR; CY; DK; FR; DE; EL; IE; IL; LV; MT; MNE; PL; PT; RO; RS; SI; ES; UK
Abstract
(Englisch)
See short description
Datenbankreferenzen
(Englisch)
Swiss Database: COST-DB of the State Secretariat for Education and Research Hallwylstrasse 4 CH-3003 Berne, Switzerland Tel. +41 31 322 74 82 Swiss Project-Number: C16.0038